These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 31516612)
1. Q-PTP is an optimized technology of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the laser therapy of melasma: A prospective split-face study. Guo X; Cai X; Jin Y; Zhang T; Wang B; Li Q Oncol Lett; 2019 Oct; 18(4):4136-4143. PubMed ID: 31516612 [TBL] [Abstract][Full Text] [Related]
2. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma. Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301 [TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy. Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE J Cosmet Laser Ther; 2015 Feb; 17(1):2-8. PubMed ID: 25151913 [TBL] [Abstract][Full Text] [Related]
4. Comparative study of dual-pulsed 1064 nm Q-switched Nd:YAG laser and single-pulsed 1064 nm Q-switched Nd:YAG laser by using zebrafish model and prospective split-face analysis of facial melasma. Jang HW; Chun SH; Park HC; Ryu HJ; Kim IH J Cosmet Laser Ther; 2017 Apr; 19(2):114-123. PubMed ID: 27911108 [TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of fractional Q-switched 1064-nm neodymium-doped yttrium aluminum garnet laser in the treatment of melasma in Chinese patients. Yue B; Yang Q; Xu J; Lu Z Lasers Med Sci; 2016 Nov; 31(8):1657-1663. PubMed ID: 27450275 [TBL] [Abstract][Full Text] [Related]
6. Treatment of melasma with a low-fluence 1064 nm Q-switched Nd:YAG laser: Laser toning in Caucasian women. Micek I; Pawlaczyk M; Kroma A; Seraszek-Jaros A; Urbańska M; Gornowicz-Porowska J Lasers Surg Med; 2022 Mar; 54(3):366-373. PubMed ID: 34473361 [TBL] [Abstract][Full Text] [Related]
7. Treatment of melasma with mixed parameters of 1,064-nm Q-switched Nd:YAG laser toning and an enhanced effect of ultrasonic application of vitamin C: a split-face study. Lee MC; Chang CS; Huang YL; Chang SL; Chang CH; Lin YF; Hu S Lasers Med Sci; 2015 Jan; 30(1):159-63. PubMed ID: 25073866 [TBL] [Abstract][Full Text] [Related]
8. Low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser for the treatment of facial melasma in Asians. Wattanakrai P; Mornchan R; Eimpunth S Dermatol Surg; 2010; 36(1):76-87. PubMed ID: 20298254 [TBL] [Abstract][Full Text] [Related]
9. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser. Alsaad SM; Ross EV; Mishra V; Miller L Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141 [TBL] [Abstract][Full Text] [Related]
10. Retreatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser in patients with melasma aggravation after previous therapy. Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE J Cosmet Laser Ther; 2015 Jun; 17(3):129-34. PubMed ID: 25415369 [TBL] [Abstract][Full Text] [Related]
11. A split-face comparison of low-fluence Q-switched Nd: YAG laser plus 1550 nm fractional photothermolysis vs. Q-switched Nd: YAG monotherapy for facial melasma in Asian skin. Kim HS; Kim EK; Jung KE; Park YM; Kim HO; Lee JY J Cosmet Laser Ther; 2013 Jun; 15(3):143-9. PubMed ID: 23607714 [TBL] [Abstract][Full Text] [Related]
12. Novel 532-nm Q-switched Nd: YAG laser for the treatment of melasma and rejuvenation: a prospective, randomized controlled comparison with 1,064-nm Q-switched Nd: YAG laser. Wu W; Su Q; Zhang Y; Du Y; Hu Y; Wang F Int J Dermatol; 2024 Sep; 63(9):1242-1251. PubMed ID: 38411341 [TBL] [Abstract][Full Text] [Related]
13. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma. Ustuner P; Balevi A; Ozdemir M J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378 [TBL] [Abstract][Full Text] [Related]
14. Split-face comparison of long-pulse-duration neodymium-doped yttrium aluminum garnet (Nd:YAG) 1,064-nm laser alone and combination long-pulse and Q-switched Nd:YAG 1,064-nm laser with carbon photoenhancer lotion for the treatment of enlarged pores in Asian women. Wattanakrai P; Rojhirunsakool S; Pootongkam S Dermatol Surg; 2010 Nov; 36(11):1672-80. PubMed ID: 20961349 [TBL] [Abstract][Full Text] [Related]
15. Combining Low Power Fractional CO Esmat S; Z Elramly A; Shahin D; Hilal RF Lasers Surg Med; 2021 Dec; 53(10):1325-1340. PubMed ID: 34164829 [TBL] [Abstract][Full Text] [Related]
16. A prospective, split-face, double-blinded, randomized study of the efficacy and safety of a fractional 1064-nm Q-switched Nd:YAG laser for photoaging-associated mottled pigmentation in Asian skin. Won KH; Lee SH; Lee MH; Rhee DY; Yeo UC; Chang SE J Cosmet Laser Ther; 2016 Nov; 18(7):381-386. PubMed ID: 27249461 [TBL] [Abstract][Full Text] [Related]
17. A randomized, observer-blinded, comparison of combined 1064-nm Q-switched neodymium-doped yttrium-aluminium-garnet laser plus 30% glycolic acid peel vs. laser monotherapy to treat melasma. Park KY; Kim DH; Kim HK; Li K; Seo SJ; Hong CK Clin Exp Dermatol; 2011 Dec; 36(8):864-70. PubMed ID: 21973194 [TBL] [Abstract][Full Text] [Related]
19. Treatment of Melasma with the Photoacoustic Twin Pulse Mode of Low-Fluence 1,064 nm Q-Switched Nd:YAG Laser. Kim JY; Choi M; Nam CH; Kim JS; Kim MH; Park BC; Hong SP Ann Dermatol; 2016 Jun; 28(3):290-6. PubMed ID: 27274626 [TBL] [Abstract][Full Text] [Related]
20. A prospective, split-face study comparing 1,064-nm picosecond Nd:YAG laser toning with 1,064-nm Q-switched Nd:YAG laser toning in the treatment of melasma. Hong JK; Shin SH; Park SJ; Seo SJ; Park KY J Dermatolog Treat; 2022 Aug; 33(5):2547-2553. PubMed ID: 35067157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]